Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1978 Feb;128(2):117–126.

Viral Hepatitis

Gary L Gitnick 1
PMCID: PMC1238013  PMID: 629050

Abstract

Viral hepatitis may be classified into three or more forms including type A hepatitis, type B hepatitis, and a group denoted as non-A non-B hepatitis which may represent viral hepatitis of one or more causes. The differentiation of these forms of hepatitis is primarily serologic. The development of antibody to hepatitis A virus can be detected by radioimmunoassay as well as by other test systems. The serologic diagnosis of type B hepatitis rests on the detection of hepatitis B surface antigen or on the development of antibody to hepatitis B core antigen or hepatitis B surface antigen. The serologic diagnosis of non-A non-B hepatitis is a diagnosis of exclusion for assay systems for this form of disease are not yet available.

A prototype hepatitis B vaccine has been prepared and is currently undergoing clinical trials. Gamma globulin is now available that contains high titered antibody against hepatitis B virus. Normal immune globulin contains high titers directed against hepatitis A virus. Therefore, for documented exposure, effective prophylaxis is available for both of these forms of acute liver disease. The past decade has resulted in rapid advances in our understanding of the pathogenesis of acute hepatitis and its extrahepatic manifestations. However, it is clear that specific treatment for acute hepatitis and the accurate description of the etiologic agents of non-A non-B hepatitis require exploration.

Full text

PDF
117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akdamar K. A., Maumus L., Cherrie Epps A., Leach R., Warren S. S.H. antigen in bile. Lancet. 1971 May 1;1(7705):909–909. doi: 10.1016/s0140-6736(71)92466-4. [DOI] [PubMed] [Google Scholar]
  2. Alpert E., Isselbacher K. J., Schur P. H. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med. 1971 Jul 22;285(4):185–189. doi: 10.1056/NEJM197107222850401. [DOI] [PubMed] [Google Scholar]
  3. Alter H. J., Blumberg B. S. Further studies on a "new" human isoprecipitin system (Australia antigen). Blood. 1966 Mar;27(3):297–309. [PubMed] [Google Scholar]
  4. Alter H. J., Chalmers T. C., Freeman B. M., Lunceford J. L., Lewis T. L., Holland P. V., Pizzo P. A., Plotz P. H., Meyer W. J., 3rd Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? N Engl J Med. 1975 Feb 27;292(9):454–457. doi: 10.1056/NEJM197502272920904. [DOI] [PubMed] [Google Scholar]
  5. BLUMBERG B. S., ALTER H. J., RIDDELL N. M., ERLANDSON M. MULTIPLE ANTIGENIC SPECIFICITIES OF SERUM LIPOPROTEINS DETECTED WITH SERA OF TRANSFUSED PATIENTS. Vox Sang. 1964 Mar-Apr;9:128–145. doi: 10.1111/j.1423-0410.1964.tb03672.x. [DOI] [PubMed] [Google Scholar]
  6. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  7. BLUMBERG B. S., DRAY S., ROBINSON J. C. Antigen polymorphism of a low-density beta-lipoprotein. Allotypy in human serum. Nature. 1962 May 19;194:656–658. doi: 10.1038/194656a0. [DOI] [PubMed] [Google Scholar]
  8. Barker L. F., Shulman N. R., Murray R., Hirschman R. J., Ratner F., Diefenbach W. C., Geller H. M. Transmission of serum hepatitis. JAMA. 1970 Mar 2;211(9):1509–1512. [PubMed] [Google Scholar]
  9. Blumberg B. S., Sutnick A. I., London W. T., Millman I. Australia antigen and hepatitis. N Engl J Med. 1970 Aug 13;283(7):349–354. doi: 10.1056/NEJM197008132830707. [DOI] [PubMed] [Google Scholar]
  10. Combes B., Shorey J., Barrera A., Stastny P., Eigenbrodt E. H., Hull A. R., Carter N. W. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971 Jul 31;2(7718):234–237. doi: 10.1016/s0140-6736(71)92572-4. [DOI] [PubMed] [Google Scholar]
  11. Dane D. S., Cameron C. H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970 Apr 4;1(7649):695–698. doi: 10.1016/s0140-6736(70)90926-8. [DOI] [PubMed] [Google Scholar]
  12. Darani M., Gerber M. Letter: Hepatitis-B antigen in vaginal secretions. Lancet. 1974 Oct 26;2(7887):1008–1008. doi: 10.1016/s0140-6736(74)92094-7. [DOI] [PubMed] [Google Scholar]
  13. Feinstone S. M., Kapikian A. Z., Purcell R. H., Alter H. J., Holland P. V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975 Apr 10;292(15):767–770. doi: 10.1056/NEJM197504102921502. [DOI] [PubMed] [Google Scholar]
  14. Fulford K. W., Dane D. S., Catterall R. D., Woof R., Denning J. V. Australia antigen and antibody among patients attending a clinic for sexually transmitted diseases. Lancet. 1973 Jun 30;1(7818):1470–1473. doi: 10.1016/s0140-6736(73)91810-2. [DOI] [PubMed] [Google Scholar]
  15. Giles J. P., McCollum R. W., Berndtson L. W., Jr, Krugman S. Relation of Australia-SH antigen to the willowbrook MS-2 strain. N Engl J Med. 1969 Jul 17;281(3):119–122. doi: 10.1056/NEJM196907172810302. [DOI] [PubMed] [Google Scholar]
  16. Gitnick G. L., Gleich G. J., Schoenfield L. J., Baggenstoss A. H., Sutnick A. I., Blumberg B. S., London W. T., Summerskill W. H. Australia antigen in chronic active liver disease with cirrhosis. Lancet. 1969 Aug 9;2(7615):285–288. doi: 10.1016/s0140-6736(69)90052-x. [DOI] [PubMed] [Google Scholar]
  17. Gocke D. J., Hsu K., Morgan C., Bombardieri S., Lockshin M., Christian C. L. Association between polyarteritis and Australia antigen. Lancet. 1970 Dec 5;2(7684):1149–1153. doi: 10.1016/s0140-6736(70)90339-9. [DOI] [PubMed] [Google Scholar]
  18. Gocke D. J., Kavey N. B. Hepatitis antigen. Correlation with disease and infectivity of blood-donors. Lancet. 1969 May 31;1(7605):1055–1059. doi: 10.1016/s0140-6736(69)91701-2. [DOI] [PubMed] [Google Scholar]
  19. Grob P. J., Jemelka H. Faecal S.H. (Australia) antigen in acute hepatitis. Lancet. 1971 Jan 30;1(7692):206–208. doi: 10.1016/s0140-6736(71)90949-4. [DOI] [PubMed] [Google Scholar]
  20. Heathcote J., Cameron C. H., Dane D. S. Hepatitis-B antigen in saliva and semen. Lancet. 1974 Jan 19;1(7847):71–73. doi: 10.1016/s0140-6736(74)92289-2. [DOI] [PubMed] [Google Scholar]
  21. Irwin G. R., Allen A. M., Bancroft W. H., Karwacki J. J., Pinkerton R. H., Russell P. K. Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers. JAMA. 1974 Mar 4;227(9):1042–1043. doi: 10.1001/jama.227.9.1042. [DOI] [PubMed] [Google Scholar]
  22. Keys T. F., Hobel C. J., Ritman S., Oh W., Gitnick G. L., Hewitt W. L. Maternal and neonatal Australia antigen. Calif Med. 1971 Dec;115(6):1–3. [PMC free article] [PubMed] [Google Scholar]
  23. Knieser M. R., Jenis E. H., Lowenthal D. T., Bancroft W. H., Burns W., Shalhoub R. Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol. 1974 Apr;97(4):193–200. [PubMed] [Google Scholar]
  24. Koretz R. L., Gitnick G. L. Prevention of post-transfusion hepatitis. Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion. Am J Med. 1975 Dec;59(6):754–760. doi: 10.1016/0002-9343(75)90460-x. [DOI] [PubMed] [Google Scholar]
  25. Koretz R. L., Suffin S. C., Gitnick G. L. Post-transfusion chronic liver disease. Gastroenterology. 1976 Nov;71(5):797–803. [PubMed] [Google Scholar]
  26. Krugman S., Giles J. P., Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA. 1967 May 1;200(5):365–373. doi: 10.1001/jama.200.5.365. [DOI] [PubMed] [Google Scholar]
  27. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  28. Linnemann C. C., Jr, Goldberg S. Letter: HBAg in breast milk. Lancet. 1974 Jul 20;2(7873):155–155. doi: 10.1016/s0140-6736(74)91574-8. [DOI] [PubMed] [Google Scholar]
  29. Magnius L. O., Espmark J. A. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol. 1972 Nov;109(5):1017–1021. [PubMed] [Google Scholar]
  30. Mahoney P., Fleischner G., Millman I., London W. T., Blumberg B. S., Arias I. M. Australia antigen: detection and transmission in shellfish. Science. 1974 Jan 11;183(4120):80–81. doi: 10.1126/science.183.4120.80. [DOI] [PubMed] [Google Scholar]
  31. McCarty D. J., Ormiste V. Arthritis and HB Ag-positive hepatitis. Arch Intern Med. 1973 Aug;132(2):264–268. [PubMed] [Google Scholar]
  32. Metselaar D., Blumberg B. S., Millman I., Parker A. M., Bagshawe A. F. Hepatitis-B antigen in colony mosquitoes. Lancet. 1973 Oct 6;2(7832):758–759. doi: 10.1016/s0140-6736(73)91038-6. [DOI] [PubMed] [Google Scholar]
  33. Nielsen J. O., Dietrichson O., Juhl E. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. Lancet. 1974 Oct 19;2(7886):913–915. doi: 10.1016/s0140-6736(74)91127-1. [DOI] [PubMed] [Google Scholar]
  34. Nielsen J. O., Nielsen M. H., Elling P. Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers. N Engl J Med. 1973 Mar 8;288(10):484–487. doi: 10.1056/NEJM197303082881002. [DOI] [PubMed] [Google Scholar]
  35. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schweitzer I. L., Wing A., McPeak C., Spears R. L. Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA. 1972 May 22;220(8):1092–1095. [PubMed] [Google Scholar]
  37. Tanno H., Fay O. H., Roncoroni M., Garcia C., Katz R. Detection of Australia antigen in urine and saliva. Acta Hepatogastroenterol (Stuttg) 1974 Oct;21(5):373–376. [PubMed] [Google Scholar]
  38. Villarejos V. M., Visoná K. A., Gutiérrez A., Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974 Dec 26;291(26):1375–1378. doi: 10.1056/NEJM197412262912602. [DOI] [PubMed] [Google Scholar]
  39. Walsh J. H., Yalow R., Berson S. A. Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis. 1970 May;121(5):550–554. doi: 10.1093/infdis/121.5.550. [DOI] [PubMed] [Google Scholar]
  40. Woolf I. L., Boyes B. E., Jones D. M., Whittaker J. S., Tapp E., MacSween R. N., Renton P. H., Stratton F., Dymock I. W. Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol. 1974 May;27(5):348–352. doi: 10.1136/jcp.27.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wright R., McCollum R. W., Klatskin G. Australia antigen in acute and chronic liver disease. Lancet. 1969 Jul 19;2(7612):117–121. doi: 10.1016/s0140-6736(69)92437-4. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES